Related Experiment Videos
Microsatellite DNA instability in benign lung diseases
Katerina Samara1, Maria Zervou, Nikolaos M Siafakas
1Department of Thoracic Medicine, Medical School, University of Crete, Heraklion 71110, Crete, Greece.
Respiratory Medicine
|July 12, 2005
Summary
Microsatellite instability (MSI) and loss of heterozygosity (LOH) are linked to benign lung diseases. Detecting these DNA alterations may help identify disease-causing genes and serve as a screening tool.
Area of Science:
- Molecular Medicine
- Genetics
- Pulmonology
Background:
- The DNA mismatch repair system (MMR) is crucial for genomic stability.
- Microsatellite (MS) DNA alterations, including loss of heterozygosity (LOH) and microsatellite instability (MSI), indicate MMR deficiency.
- While MSI and LOH are known in malignancies, they are also increasingly found in benign conditions.
Purpose of the Study:
- To review the role of microsatellite instability (MSI) in benign lung diseases.
- To explore the potential of MSI and LOH as biomarkers in non-cancerous pulmonary conditions.
Main Methods:
- This study is a review of existing literature on MSI in benign lung diseases.
- Analysis of reported findings on microsatellite alterations in conditions like asthma, COPD, sarcoidosis, and idiopathic pulmonary fibrosis.
Main Results:
- Microsatellite alterations (MSI and LOH) have been detected in various benign lung diseases.
- These genetic changes suggest a potential role for MMR deficiency in the pathogenesis of these conditions.
Conclusions:
- Detecting genetic alterations at the MS DNA level can identify potential disease-causing genes in benign lung diseases.
- MSI and LOH may serve as valuable genetic screening tools in molecular epidemiology for pulmonary conditions.